STAT Plus: Illumina earnings points to worrying signs for consumer genetics industry
APSTOCK
New figures suggest consumer genetics companies are ordering fewer genotyping arrays, which suggests customers are buying fewer DNA tests.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario